CPEB4 and central nervous system cancer: Results in this study demonstrated that silencing lncRNA FOXD2-AS1 inhibited migration, invasion, proliferation and drug resistance of drug-resistant glioma cells and promoted their apoptosis via enhancing the expression of miR-98-5p or decreasing CPEB4.